Keywords: Dabi; dabigatran; DTI; direct thrombin inhibitor; PT; prothrombin time; APTT; activated partial thromboplastin time; TT; thrombin time; ECA; ecarin clotting assay; HTI; Hemoclot Thrombin Inhibitors; LC-MS/MS; liquid chromatography-tandem mass spectrometry
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: aPTT; Activated partial thromboplastin time; α2M-Thrombin; Alpha2 macroglobulin-thrombin; Anti-FXa; Anti-factor X activated; CAT; Calibrated automated thrombography; DVT; Deep venous thromboembolism; ETP; Endogenous thrombin potential; FVIII; Factor VI
Keywords: Hemostasis; Fucoidan; Hemophilia; NMR; Structure; Screening; NASP; non-anticoagulant sulfated polysaccharide; TFPI; tissue factor pathway inhibitor; TF; tissue factor; s.c.; subcutaneous; p.o.; per os (oral); Mw; molecular weight; polyD; polydispersity; O
Keywords: ALB; albumin; ALT; alanine aminotransferase; ALP; alkaline phosphatase; AST; aspartate aminotransferase; APTT; activated partial thromboplastin time; BW; body weight; BUN; urea nitrogen; CK; creatine kinase; CRE; creatinine; FIB; fibrinogen; GLU; glucose;
Keywords: aPTT; activated partial thromboplastin time; CLP; cecal ligation and puncture; EPCR; endothelial PC receptor; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; HR; heart rates; ICAM-1; intercellular adhesion molecule; i.p.; injected intraperitoneally; LPS;
Keywords: ADP; adenosine diphosphate; ANOVA; analysis of variance; APC; allophycocyanin; aPTT; activated partial thromboplastin time; COX-1; cyclooxygenase-1; CVD; cardiovascular disease; C3GE; cyanidin-3-glucoside equivalents; FBC; full blood count; FITC; fluoresc
Keywords: Anaphylaxis; mast cell; bradykinin; mouse models; tryptase; contact system; ACE; Angiotensin-converting enzyme; Anti-Xa; Anti-factor Xa activity; aPTT; Activated partial thromboplastin time; Bdkrb1; B1R coding gene; Bdkrb2; B2R coding gene; B1R; Bradyki
Keywords: VTE; Venous thromboembolism; CVCs; Central venous catheters; aPTT; Activated partial thromboplastin time; CT; Computed tomography; CI; Confidence interval; (F1.2); Prothrombin fragment 1.2; (TAT); Thrombin-antithrombin; FVIII: C; FVIII coagulant activity;
Keywords: TF; tissue factor; APTT; activated partial thromboplastin time; PFP; platelet free plasma; PPP; platelet poor plasma; Coagulation tests; thrombodynamics; pre-analytical variables;
Keywords: PUC; Premature uterine contractions; PPROM; Preterm premature rupture of membranes; PTL; Preterm labor; aPTT; Activated partial thromboplastin time; PT; Prothrombin time; PT F1Â +Â 2; Prothrombin Fragments F1Â +Â 2; TAT; Thrombin anti thrombin; PAI 1; Pla
Keywords: CAT; calibrated automated thrombography; TF; tissue factor; PPP; platelet-poor plasma; ESS; enhanced single spin; CTI; corn trypsin inhibitor; ETP; endogenous thrombin potential; ttpeak; time to peak; APTT; activated partial thromboplastin time; MF; membr
Keywords: Anti-FXa; anti-activated factor X (activity); aPTT; activated partial thromboplastin time; CTAD; citrate, theophylline, adenosine, dipyridamole; CV; coefficient of variation; ELISA; enzyme-linked immunosorbent assay; FV; (coagulation) factor V; INR; inter
Keywords: CPB; cardiopulmonary bypass; TG; thrombin generation; CAT; calibrated automated thrombography; TFPI; tissue factor pathway inhibitor; AT; antithrombin; CABG; coronary artery bypass grafting; ACT; activated clotting time; UFH; unfractionated heparin; PPP;
Keywords: ADR; adverse drug reaction; AE; adverse event; AML; acute myeloid leukemia; ALL; acute lymphoblastic leukemia; APL; acute promyelocytic leukemia; APTT; activated partial thromboplastin time; AT; antithrombin; CLL; chronic lymphocytic leukemia; CML; chroni
Keywords: Anticoagulants/Administration and Dosage; Atrial Fibrillation; Drug Administration Schedule; Drug Monitoring; Thrombosis/Drug Therapy; Endoscopy; Gastrointestinal; AF; atrial fibrillation; aPTT; activated partial thromboplastin time; CrCl; creatinine clea
Keywords: APTT; activated partial thromboplastin time; Bax; Bcl-2-associated X protein; Bcl-2; B cell lymphoma-2; HLP; hirulog-like peptide; LMWH; low-molecular-weight heparin; MDA; malondialdehyde; NSS; neurological severity score; PAR; protease-activated receptor
Keywords: 5-FU; 5-fluorouracil; CRC; curcumin; TCS; thiolated chitosan; FT-IR; Fourier transform infrared spectroscopy; DDA; degree of deacetylation; DLS; dynamic light scattering; PBS; phosphate buffered saline; SEM; scanning electron microscope; FBS; fetal bovine
Keywords: APTT; activated partial thromboplastin time; Bb; fragment of complement of factor B; BBB; blood brain barriers; BCI; blood coagulation index; C3a, C4a and C5a; peptide anaphylatoxins; C4d; cleavage product of complement component C4; CH-50; hemolityc comp
Keywords: Space radiation; Solar particle event; Radiation countermeasures; Acute effects of radiation; Long-term effects of radiation; ARS; acute radiation sickness; aPTT; activated partial thromboplastin time; BBI; Bowman-Birk inhibitor; BBIC; BBI concentrate;
Keywords: ABPM; ambulatory blood pressure monitoring; ACE; angiotensin converting enzyme; ACR; albumin to creatinine ratio; ALT; alanine transaminase; aPTT; activated partial thromboplastin time; ARB; angiotensin receptor blocker; AST; aspartate transaminase; BMI;
Keywords: APTT; activated partial thromboplastin time; BMI; body mass index; CLT; clot lysis time; CRP; C-reactive protein; d-Dmax; maximum d-dimer levels in the clot lysis assay; d-Drate; maximum rate of increase in d-dimer levels in the clot lysis assay; DTC; dig
Keywords: APTT; activated partial thromboplastin time; ETP; endogenous thrombin potential; OC; oral contraceptive(s); OCP; overall coagulation potential; OFP; overall fibrinolytic potential; OHP; overall haemostasis potential; VT; venous thrombosis; endogenous thro
Keywords: ACT; activated clotting time; APTT; activated partial thromboplastin time; ARF; acute renal failure; BPT; bypass time; BW; body weight; CABG; coronary artery bypass graft; CCT; crossclamp time; CHF; congestive heart failure; CVA; cerebrovascular accident;
Keywords: HCT; Haematocrit; CCHD; Cyanotic congenital heart disease; CT; Clot time; CFT; Clot formation time; MCF; Maximum clot firmness; CF; Clauss fibrinogen concentration; WBFC; Whole blood fibrinogen concentration; PT; Prothrombin time; APTT; Activated partial
Keywords: ABC; Activity Based Costing; aPTT; activated Partial Thromboplastin Time; BMI; Body Mass Index; CT; computerized tomography; C-US; compression ultrasonography; DVT; deep vein thrombosis; ECG; electrocardiogram; INR; International Normalized Ratio; LMWH; l
Keywords: APTT; Activated partial thromboplastin time; ASIS; recombinant active site-inhibited factor VIIa; BD; brain dead; BSA; Bovine serum albumin; CCP; Cerebral perfusion pressure; CT; Clotting time; CTI; Corn trypsin inhibitor; ETP; endogenous thrombin potenti
Keywords: ACS; acute coronary syndrome; ANCOVA; analysis of covariance; aPTT; activated partial thromboplastin time; ASA; acetylsalicylic acid; CI; confidence interval; Cmax; maximum plasma concentration; Ctrough; minimum plasma concentration; CV; coefficient of va
Keywords: A/G; albumin/globulin ratio; ALP; alkaline phosphatase; ALT; Alanine aminotransferase; APTT; activated partial thromboplastin time; BUN; blood urea nitrogen; CK; creatine kinase; EFSA; European Food Safety Authority; FDA; Food and Drug Administration; RBC
Keywords: PT; prothrombin time; aPTT; activated partial thromboplastin time; PVT; portal vein thrombosis; LMWH; low molecular weight heparin; DVT; deep vein thrombosis; VKA; vitamin K antagonists; NAFLD; non-alcoholic fatty liver disease; NASH; non-alcoholic steato
Keywords: GAG; glycosaminoglycan; FG; fucosylated glycosaminoglycan; DFG; depolymerized fucosylated glycosaminoglycan; UFH; unfractionated heparin; LMWH; low-molecular-weight heparin; DD; deacetylation degree; GalNAc4S6S; 4,6-O-disulfated N-acetylgalactosamine; Glc
Keywords: PT, Prothrombin Time; APTT, Activated Partial Thromboplastin Time; μg/ml, micrograms per milliliters; DMSO, dimethyl sulfoxideMedicinal plants; Anticoagulant; PT; APTT; Cheminformatics
Characteristics and resource utilization of patients presenting to the ED from mass gathering events
Keywords: MGEs; mass gathering events; ED; emergency department; EMRs; electronic medical records; PMH; past medical history; WHO; World Health Organization; GMF; general medicine floor; ICU; intensive care unit; GMF obs; general medicine observation unit; NSAID; n
Fibrinolytic potential of DS-1040, a novel orally available inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)
Keywords: APTT; activated partial thromboplastin time; TAFIa; activated thrombin-activatable fibrinolysis inhibitor; PCI; carboxypeptidase inhibitor from potato tuber; CPN; carboxypeptidase N; PRP; platelet-rich plasma; PT; prothrombin time; rt-PA; recombinant tiss
Primary and metastatic malignancies of the lung: Retrospective analysis of the CT-guided high-dose rate brachytherapy (CT-HDRBT) ablation in tumours <4âcm and â¥4âcm
Keywords: CT-HDRBT; CT-guided high dose rate brachytherapy; SBRT; stereotactic body radiotherapy; RFA; radiofrequency ablation; MWA; microwave ablation; LITT; laser induced thermotherapy; CTx; chemotherapy; RTx; radiation therapy; pLTC; primary local tumour control
Simple method for removing DOACs from plasma samples
Keywords: DOAC; Dabigatran; Apixaban; Rivaroxaban; Edoxaban; APTT; dRVVT; Lupus anticoagulant; Clotting tests; DOAC adsorbent;
Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia
Keywords: 4T; Thrombocytopenia, Timing of platelet count fall, Thrombosis or other sequelae, other causes of Thrombocytopenia; Ab; antibody; ACT; activated clotting time; aPTT; activated partial thromboplastin time; AVR; aortic valve repair; CABG; coronary artery b
Pleiotropic effects of n-6 and n-3 fatty acid-related genetic variants on circulating hemostatic variables
Keywords: AA; African American; aPTT; activated partial thromboplastin time; ARIC; the Atherosclerosis Risk in Communities Study; CHS; the Cardiovascular Health Study; DHA; docosahexaenoic acid; DPA; docosapentaenoic acid; EA; European ancestry; EPA; eicosapentaeno
Assessment of two contact activation reagents for the diagnosis of congenital factor XI deficiency
Keywords: FXI deficiency; APTT; Silica; Ellagic acid; FXI:C; rs1801020;
Subcutaneous administration of Lyso-phosphatidylserine nanoparticles induces immunological tolerance towards Factor VIII in a Hemophilia A mouse model
Keywords: FVIII; Factor VIII; PS; phosphatidylserine; HA; Hemophilia A; Tregs; regulatory T cells; Lyso-PS; Lyso-phosphatidylserine; DMPC; dimyrisotylphosphatidylcholine; OVA; ovalbumin; GFP; green fluorescent protein; SC; subcutaneous; IV; intravenous; APC; antige
Hemostasis and uterine contraction promoting effect of the extract from drugs in the Zi-Yin-Tiao-Jing granule, a traditional Chinese compound preparation
Keywords: APTT; activated partial thromboplastin time; FIB; fibrinogen; HPLC; High-performance liquid chromatography; PDUB; Perimenopausal dysfunctional uterine bleeding; PT; prothrombin time; SD; standard deviation; TSG; tetrahydroxystilbene glucoside; UV; Ultravi
Antithrombotic components of Malus halliana Koehne flowers
Keywords: Malus halliana flowers; Chemical composition; Column chromatography; Anticoagulant; Antithrombotic; APTT; activated partial thrombin time; PT; prothrombin time; TT; thrombin time; FIB; fibrinogen; WBV; whole blood viscosity; PV; plasma viscosity; HCT; hem
Comprehensive characteristics of the anticoagulant activity of dabigatran in relation to its plasma concentration
Keywords: APTT; activated partial thromboplastin time; APTT-Cepha; APTT using Cephascreen® (Diagnostica Stago) reagent; APTT-PSL; APTT using Pathromtin®SL (Siemens Healthcare) reagent; ANOVA; analysis of variance; CAT; calibrated automated thrombinography; CT; cl
Measurement of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma using automated online solid-phase extraction combined with ultra-performance liquid chromatography-tandem mass spectrometry and its comparison with coagulation assays
Keywords: aPTT; activated partial thromboplastin time; BEH; bridged ethyl hybrid; CV; coefficient of variation; DOACs; direct oral anticoagulants; DTI; direct thrombin inhibitor(s); IS; internal standard; MRM; multiple reaction monitoring mode; MS/MS; tandem mass s
Partial thromboplastin time is more predictive of bleeding than anti-Xa levels in heparinized pediatric patients after cardiac surgery
Keywords: anticoagulation; heparin; bleeding; thrombosis; congenital heart disease; Anti-Xa; anti-factor Xa activity; aPTT; activated partial thromboplastin time; ATIII; antithrombin III; CI; confidence interval; CICU; cardiac intensive care unit; IQR; interquartil
Effects of Danhong Injection on platelet aggregation in hyperlipidemia rats
Keywords: DHI; Danhong Injection; 6-keto-PGF1a; 6-keto-prostaglandin F1a; TG; triglyceride; TC; total cholesterol; LDL-C; low density lipoprotein cholesterol; HDL-C; high density lipoprotein cholesterol; PAF; platelet activating factor; GP IIb/IIIa; platelet membra
The Evolving Face of Myocardial Reperfusion in Acute Coronary Syndromes: A Primer for the Internist
Keywords: ACS; acute coronary syndrome; ACT; activated clotting time; ADP; adenosine diphosphate; AHA/ACC; American Heart Association American/College of Cardiology; APTT; activated partial thromboplastin time; AVM; arteriovenous malformation; BID; twice daily; CAB
QCM-D surpassing clinical standard for the dose administration of new oral anticoagulant in the patient of coagulation disorders
Keywords: Dabigatran; Coagulation disorders; Patient plasma; aPTT; PiCT; QCM-D;
Outcomes of endoscopic intervention for overt GI bleeding in severe thrombocytopenia
Keywords: aPTT; activated partial thromboplastin time; CI; confidence interval; GIB; gastrointestinal bleeding; ICU; intensive care unit; INR; international normalized ratio; LC; liver cirrhosis; NLC; non-liver cirrhosis; OR; odds ratio; PC; platelet count; pRBC; p
An arabinogalactan-glycoconjugate from Genipa americana leaves present anticoagulant, antiplatelet and antithrombotic effects
Keywords: ADP; adenosine diphosphate; aPTT; activated partial thromboplastin time; HMWH; high-molecular-weight heparin; PBS; phosphate buffered saline; PT; prothrombin time; TT; thrombin time; PE; Ga-polysaccharide extract of Genipa americana; PF; polysaccharide fr
Isolation, characterization and bioactive potential of sulfated galactans from Spyridia hypnoides (Bory) Papenfuss
Keywords: Red seaweed; Sulfated galactans; Free radical scavenger; aPTT; PT;